E-LIB Suche - Ergebnisse für: Bernstein, David I.

1

Progress with COVID vaccine development and implementation:

Titball, Richard W. ; Bernstein, David I. ; Fanget, Nicolas V. J....
npj Vaccines. 9 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits P..:

Hu, Xintao ; Karthigeyan, Krithika P ; Herbek, Savannah...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

3

How Allergists Can Perform an Occupational History in Every..:

Bernstein, David I. ; Pacheco, Karin ; Lemiere, Catherine
The Journal of Allergy and Clinical Immunology: In Practice. , 2024

Link: https://doi.org/10.1016/..

4

Anaphylaxis in Clinical Trials of Sublingual Immunotherapy ..:

Nolte, Hendrik ; Calderon, Moisés A. ; Bernstein, David I....
The Journal of Allergy and Clinical Immunology: In Practice. 12 (2024) 1 - p. 85-95.e4 , 2024

Link: https://doi.org/10.1016/..

5

A chimeric haemagglutinin-based universal influenza virus v..:

Bliss, Carly M. ; Nachbagauer, Raffael ; Mariottini, Chiara...
eBioMedicine. 104 (2024) - p. 105153 , 2024

Link: https://doi.org/10.1016/..

6

Selection, activity, and nuclease stabilization of cross-ne..:

Schump, Michael D. ; Bernstein, David I. ; Bravo, Fernando J..
Virology. 589 (2024) - p. 109916 , 2024

Link: https://doi.org/10.1016/..

7

Safety and Immunogenicity of a Delayed Heterologous Avian I..:

El Sahly, Hana M ; Yildirim, Inci ; Frey, Sharon E...
The Journal of Infectious Diseases. 229 (2023) 2 - p. 327-340 , 2023

Link: https://doi.org/10.1093/..

8

Extrapolating Evidence-Based Medicine of AIT Into Clinical ..:

Calderon, Moisés A. ; Casale, Thomas B. ; Nelson, Harold S....
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 4 - p. 1100-1115 , 2023

Link: https://doi.org/10.1016/..

9

A Multicenter, Controlled Human Infection Study of Influenz..:

Ortiz, Justin R ; Bernstein, David I ; Hoft, Daniel F...
The Journal of Infectious Diseases. 228 (2023) 3 - p. 287-298 , 2023

Link: https://doi.org/10.1093/..

10

Intermittent therapy with helicase-primase inhibitor IM-250..:

Bernstein, David I. ; Sawtell, Nancy M. ; Bravo, Fernando J....
Antiviral Research. 219 (2023) - p. 105733 , 2023

Link: https://doi.org/10.1016/..

11

Safety, efficacy, and immunogenicity of a replication-defec..:

Das, Rituparna ; Blázquez-Gamero, Daniel ; Bernstein, David I...
The Lancet Infectious Diseases. 23 (2023) 12 - p. 1383-1394 , 2023

Link: https://doi.org/10.1016/..

12

Safety and Immunogenicity of a monovalent inactivated influ..:

Winokur, Patricia L ; Hegmann, Theresa E ; Keitel, Wendy A...
Clinical Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

13

House dust mite sublingual immunotherapy tablet safety in a..:

Horn, Andreas ; Bernstein, David I. ; Okubo, Kimihiro...
Annals of Allergy, Asthma & Immunology. 130 (2023) 6 - p. 797-804.e2 , 2023

Link: https://doi.org/10.1016/..

14

Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine..:

Neuzil, Kathleen M ; Anderson, Evan J ; Frenck, Robert W...
Clinical Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

15

Safety and immunogenicity of Multimeric-001 (M-001) followe..:

Atmar, Robert L. ; Bernstein, David I. ; Winokur, Patricia...
Vaccine. 41 (2023) 16 - p. 2716-2722 , 2023

Link: https://doi.org/10.1016/..